A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

Inclusion Criteria

• •Must meet at least 3 of the following criteria for treatment in the face with at least 2 JUVÉDERM products, per investigator's assessment:
• •* Minimal, moderate, or severe on Allergan Temple Hollowing Scale (ATHS)
• •* Moderate or severe for both eyes on Allergan Infraorbital Hollow Scale (AIHS)
• •* Moderate or severe on Allergan Cheek Smoothness Scale (ACSS)
• •* Moderate, significant, or severe on Mid-face Volume Deficit Scale (MFVDS)
• •* Moderate or severe on Nasolabial Fold Severity Scale (NLFSS)
• •* Minimal, mild, or moderate on Allergan Lip Fullness Scale 2 (ALFS2)
• •* Moderate or severe on Allergan Chin Retrusion Scale (ACRS)
• •* Moderate or severe on Allergan Loss of Jawline Definition Scale (ALJDS)
• •Must be in good health as determined by subject's medical history, physical examination, and vital sign measurements.